List of Tables
Table 1. Biotherapeutics Cell Line Development Market Trends
Table 2. Biotherapeutics Cell Line Development Market Drivers & Opportunity
Table 3. Biotherapeutics Cell Line Development Market Challenges
Table 4. Biotherapeutics Cell Line Development Market Restraints
Table 5. Global Biotherapeutics Cell Line Development Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Biotherapeutics Cell Line Development Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Biotherapeutics Cell Line Development Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Biotherapeutics Cell Line Development Product Type
Table 9. Key Companies Time to Begin Mass Production of Biotherapeutics Cell Line Development
Table 10. Global Biotherapeutics Cell Line Development Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotherapeutics Cell Line Development as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Biotherapeutics Cell Line Development Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Biotherapeutics Cell Line Development Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Biotherapeutics Cell Line Development Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Biotherapeutics Cell Line Development Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Biotherapeutics Cell Line Development Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Biotherapeutics Cell Line Development Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Biotherapeutics Cell Line Development Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Biotherapeutics Cell Line Development Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Biotherapeutics Cell Line Development Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Biotherapeutics Cell Line Development Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Biotherapeutics Cell Line Development Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Biotherapeutics Cell Line Development Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Biotherapeutics Cell Line Development Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Biotherapeutics Cell Line Development Sales Value by Region (2019-2024) & (%)
Table 27. Global Biotherapeutics Cell Line Development Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Biotherapeutics Cell Line Development Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Biotherapeutics Cell Line Development Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Biotherapeutics Cell Line Development Sales Value, (2025-2030) & (US$ Million)
Table 31. Becton Dickinson & Company Basic Information List
Table 32. Becton Dickinson & Company Description and Business Overview
Table 33. Becton Dickinson & Company Biotherapeutics Cell Line Development Products, Services and Solutions
Table 34. Revenue (US$ Million) in Biotherapeutics Cell Line Development Business of Becton Dickinson & Company (2019-2024)
Table 35. Becton Dickinson & Company Recent Developments
Table 36. Beckman Coulter Basic Information List
Table 37. Beckman Coulter Description and Business Overview
Table 38. Beckman Coulter Biotherapeutics Cell Line Development Products, Services and Solutions
Table 39. Revenue (US$ Million) in Biotherapeutics Cell Line Development Business of Beckman Coulter (2019-2024)
Table 40. Beckman Coulter Recent Developments
Table 41. Boehringer Ingelheim Group Basic Information List
Table 42. Boehringer Ingelheim Group Description and Business Overview
Table 43. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Products, Services and Solutions
Table 44. Revenue (US$ Million) in Biotherapeutics Cell Line Development Business of Boehringer Ingelheim Group (2019-2024)
Table 45. Boehringer Ingelheim Group Recent Developments
Table 46. Catalent Inc. Basic Information List
Table 47. Catalent Inc. Description and Business Overview
Table 48. Catalent Inc. Biotherapeutics Cell Line Development Products, Services and Solutions
Table 49. Revenue (US$ Million) in Biotherapeutics Cell Line Development Business of Catalent Inc. (2019-2024)
Table 50. Catalent Inc. Recent Developments
Table 51. CMC Biologics A/S Basic Information List
Table 52. CMC Biologics A/S Description and Business Overview
Table 53. CMC Biologics A/S Biotherapeutics Cell Line Development Products, Services and Solutions
Table 54. Revenue (US$ Million) in Biotherapeutics Cell Line Development Business of CMC Biologics A/S (2019-2024)
Table 55. CMC Biologics A/S Recent Developments
Table 56. Lonza Group Ltd. Basic Information List
Table 57. Lonza Group Ltd. Description and Business Overview
Table 58. Lonza Group Ltd. Biotherapeutics Cell Line Development Products, Services and Solutions
Table 59. Revenue (US$ Million) in Biotherapeutics Cell Line Development Business of Lonza Group Ltd. (2019-2024)
Table 60. Lonza Group Ltd. Recent Developments
Table 61. EMD Millipore Basic Information List
Table 62. EMD Millipore Description and Business Overview
Table 63. EMD Millipore Biotherapeutics Cell Line Development Products, Services and Solutions
Table 64. Revenue (US$ Million) in Biotherapeutics Cell Line Development Business of EMD Millipore (2019-2024)
Table 65. EMD Millipore Recent Developments
Table 66. Partec (Sysmex Corporation) Basic Information List
Table 67. Partec (Sysmex Corporation) Description and Business Overview
Table 68. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Products, Services and Solutions
Table 69. Revenue (US$ Million) in Biotherapeutics Cell Line Development Business of Partec (Sysmex Corporation) (2019-2024)
Table 70. Partec (Sysmex Corporation) Recent Developments
Table 71. ProBioGen AG Basic Information List
Table 72. ProBioGen AG Description and Business Overview
Table 73. ProBioGen AG Biotherapeutics Cell Line Development Products, Services and Solutions
Table 74. Revenue (US$ Million) in Biotherapeutics Cell Line Development Business of ProBioGen AG (2019-2024)
Table 75. ProBioGen AG Recent Developments
Table 76. Selexis SA Basic Information List
Table 77. Selexis SA Description and Business Overview
Table 78. Selexis SA Biotherapeutics Cell Line Development Products, Services and Solutions
Table 79. Revenue (US$ Million) in Biotherapeutics Cell Line Development Business of Selexis SA (2019-2024)
Table 80. Selexis SA Recent Developments
Table 81. Sigma-Aldrich Co. LLC. Basic Information List
Table 82. Sigma-Aldrich Co. LLC. Description and Business Overview
Table 83. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Products, Services and Solutions
Table 84. Revenue (US$ Million) in Biotherapeutics Cell Line Development Business of Sigma-Aldrich Co. LLC. (2019-2024)
Table 85. Sigma-Aldrich Co. LLC. Recent Developments
Table 86. Sony Biotechnology Inc. Basic Information List
Table 87. Sony Biotechnology Inc. Description and Business Overview
Table 88. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Products, Services and Solutions
Table 89. Revenue (US$ Million) in Biotherapeutics Cell Line Development Business of Sony Biotechnology Inc. (2019-2024)
Table 90. Sony Biotechnology Inc. Recent Developments
Table 91. Thermo Fisher Scientific Inc. Basic Information List
Table 92. Thermo Fisher Scientific Inc. Description and Business Overview
Table 93. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Products, Services and Solutions
Table 94. Revenue (US$ Million) in Biotherapeutics Cell Line Development Business of Thermo Fisher Scientific Inc. (2019-2024)
Table 95. Thermo Fisher Scientific Inc. Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Biotherapeutics Cell Line Development Downstream Customers
Table 99. Biotherapeutics Cell Line Development Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Biotherapeutics Cell Line Development Product Picture
Figure 2. Global Biotherapeutics Cell Line Development Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Biotherapeutics Cell Line Development Sales Value (2019-2030) & (US$ Million)
Figure 4. Biotherapeutics Cell Line Development Report Years Considered
Figure 5. Global Biotherapeutics Cell Line Development Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Biotherapeutics Cell Line Development Revenue in 2023
Figure 7. Biotherapeutics Cell Line Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Transfection & Selection Picture
Figure 9. Single Cell Cloning Picture
Figure 10. Global Biotherapeutics Cell Line Development Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Biotherapeutics Cell Line Development Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of In-house
Figure 13. Product Picture of Outsource
Figure 14. Product Picture of Hybrid
Figure 15. Product Picture of Do-It-Yourself (DIY)
Figure 16. Global Biotherapeutics Cell Line Development Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Biotherapeutics Cell Line Development Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Biotherapeutics Cell Line Development Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Biotherapeutics Cell Line Development Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Biotherapeutics Cell Line Development Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Biotherapeutics Cell Line Development Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Biotherapeutics Cell Line Development Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Biotherapeutics Cell Line Development Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Biotherapeutics Cell Line Development Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Biotherapeutics Cell Line Development Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Biotherapeutics Cell Line Development Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Biotherapeutics Cell Line Development Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Biotherapeutics Cell Line Development Sales Value (%), (2019-2030)
Figure 29. United States Biotherapeutics Cell Line Development Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Biotherapeutics Cell Line Development Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Biotherapeutics Cell Line Development Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Biotherapeutics Cell Line Development Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Biotherapeutics Cell Line Development Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Biotherapeutics Cell Line Development Sales Value by Application (%), 2023 VS 2030
Figure 35. China Biotherapeutics Cell Line Development Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Biotherapeutics Cell Line Development Sales Value by Type (%), 2023 VS 2030
Figure 37. China Biotherapeutics Cell Line Development Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Biotherapeutics Cell Line Development Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Biotherapeutics Cell Line Development Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Biotherapeutics Cell Line Development Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Biotherapeutics Cell Line Development Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Biotherapeutics Cell Line Development Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Biotherapeutics Cell Line Development Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Biotherapeutics Cell Line Development Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Biotherapeutics Cell Line Development Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Biotherapeutics Cell Line Development Sales Value by Application (%), 2023 VS 2030
Figure 47. India Biotherapeutics Cell Line Development Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Biotherapeutics Cell Line Development Sales Value by Type (%), 2023 VS 2030
Figure 49. India Biotherapeutics Cell Line Development Sales Value by Application (%), 2023 VS 2030
Figure 50. Biotherapeutics Cell Line Development Industrial Chain
Figure 51. Biotherapeutics Cell Line Development Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
